Clinical Trial Update: Single Dose Study to Measure Blood Levels and Safety of a Drug for Children With Overactive Bladder [Phase 1]

View source ↗

Summary

Phase 1 single-dose pediatric trial to measure blood levels and safety of a drug for overactive bladder and neurogenic detrusor overactivity; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Overactive Bladder

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Overactive Bladder, Neurogenic Detrusor Overactivity | Phase 1 | Status: COMPLETED